供肝门静脉与受体门静脉端端吻合。
结论：人体肝门静脉系可能与经络冲脉密切相关。
Conclusion the human hepatic portal vein system possibly is close related with the Chong Vessel.
在非肝硬变对照组患者中，肝门静脉灌注明显好于肝硬变患者。
As perfusion of portal vein to liver was concerned, it was significantly better in the control group than in those who suffered from liver cirrhosis.
目的探讨晚期肝门部胆管癌患者经皮经肝门静脉栓塞术的护理。
Objective: Researching the effect of applying selective portal vein embolization (SPVE) in the primary hepatic carcinoma patients.
目的研究肝动脉化疗栓塞基础上经皮经肝门静脉灌注化疗治疗晚期肝癌的疗效。
Objective To study the effect of transcatheter chemoembolization(TACE) plus percutaneous transhepatic portochemotherapy(PTP)for the treatment of primary liver cancer(PLC).
肝门静脉血流速度变化及肝右静脉多普勒频谱图异常有助于脂肪肝的早期诊断及预后判断。
To investigate the diagnostic value of measuring blood velocity in right branch of portal vein and Dopplers onographic waveforms in right hepatic vein by CDFI on Fatty Liver Disease.
目的利用MSCT对正常人的肝门静脉和脾静脉进行研究与测量，求得其解剖学数据，供临床参考。
Objective to study normal hepatic portal veins by means of multi-slice ct (MSCT) so as to provide anatomical data for clinical reference.
使用美国HP5500型超声仪，由同一技术人员操作，测量肝门静脉、脾静脉内径及平均血流速度。
American HP5500 ultrasound instrument was used to determine the diameters and average velocities of portal vein and splenic vein.
目的探讨自体骨髓干细胞肝门静脉移植对猕猴急性肝损伤的治疗作用和为人类肝损伤治疗提供依据和方法。
Objective a monkey model was used to determine the feasibility of treating acute liver necrosis by injecting autologous bone marrow stem cells via the portal vein.
方法：49 例无手术指征肝癌患者，行单纯肝动脉栓塞与在肝动脉栓塞的基础上行肝门静脉化疗的对照研究。
Methods: 49 patients with late liver carcinoma were treated with embolism of hepatic artery and combined with chemotherapy through portal vein were reported.
目的：利用管道铸型标本断层摄影法对肝门静脉系统进行三维重建，为腹腔镜肝切除手术提供可靠的解剖学依据。
OBJECTIVE: To explore three-dimensional reconstruction of hepatic portal vein by laminagraphy of cast specimens to provide anatomic basis for hepatectomy.
方法应用彩色多普勒超声对56例肝移植患者术前及术后移植肝门静脉、肝动脉血流及肝动脉阻力系数（RI）进行监测。
Methods Portal venous blood flow, hepatic arterial blood flow and resistance index(RI) were determined by duplex Doppler sonography in 56 patients subjected to liver transplantation.
同时血糖浓度与肝门静脉和肝静脉中的胰岛素浓度差值显示了很好的负相关关系。结论该油相制剂能有效保护胰岛素的活性。
Moreover the concentration of blood glucose was negatively correlative to the difference of the blood insulin concentrations between hepatic portal vein and hepatic vein.
在留取再灌注后的标本时测量肝动脉和门静脉的血流。
Hepatic artery and PV blood flows were measured at post reperfusion collection times.
结论：肝癌患者舌下络脉宽度与肝门脉系统中门静脉内径和脾静脉内径密切相关。
Conclusion: the width of lingual vein is closely correlated with the diameters of portal vein and splenic vein in patients with primary liver cancer.
结果患者出现门静脉血栓形成，肝栓塞坏死。
Results The patient was found to have destructive damage of portal vein.
各组术后均有1例死亡。吻合口狭窄血管并发症均在组1发生：2例发生在门静脉，1例在肝动脉，1例在右肝静脉。
Postoperative death occurred in 1 patient in each group. Vascular complications included anastomotic strictures: 2 portal vein (PV), 1 hepatic artery (HA), and 1 RHV anastomotic strictures; all in GI.
目的总结胰源性左侧肝外门静脉高压症(LEPH)临床特点、诊断和治疗经验。
Objective To summarize the experience in diagnosis and treatment of left-sided extrahepatic portal hypertension (LEPH).
目的研究经颈静脉途径肝内门体静脉内支架分流术TIPS S术后肝性脑病的发生与门静脉血流方向的关系。
Objective: to study the relationship between hepatic encephalopathy and blood flow direction of intra hepatic portal vein after transjugular intrahepatic portosystemic stent shunt (TIPSS).
术后并发症与肝血流、门静脉主干血流速度变化有关。
The postoperative complications were associated with the change of hepatic blood flow and velocity in the main portal vein.
且门静脉、肝动脉再灌注由血管夹控制。
The portal vein and the hepatic artery reperfusion were controlled by artery clamp.
门静脉灌注压可间接反映供肝质量，对评价供肝质量更具否定意义。
Measurement of the portal vein pressure can indirectly reflect the donor liver quality, which is more meaningful for evaluation of the donor liver quality.
癌组织中VEGF-C的表达与门静脉癌栓、肝门淋巴结转移和复发有关（P<0.05）。
The expression of VEGF-C was correlated with portal vein-emboli, lymph node metastasis and recurrence(P<0.05).
目的探讨超声检测肝纤维化胆囊壁厚度与门静脉压力变化的关系。
Portal venous pressure and gallbladder wall thickness were measured by ultrasound on different stages of hepatic fibrosis.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
无菌下取回盲部淋巴结、胰腺、脾、肝、门静脉血和盲肠内容做细菌培养、计数。
Bacterial culture and count of mesenteric lymph nodes, pancreas, spleen, liver, portal blood and cecal contents were measured with aseptic manipulation.
无菌下取回盲部淋巴结、胰腺、脾、肝、门静脉血和盲肠内容做细菌培养、计数。
Bacterial culture and count of mesenteric lymph nodes, pancreas, spleen, liver, portal blood and cecal contents were measured with aseptic manipulation.
应用推荐